Cargando…

Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate

In this study, silkworm larvae were used for expression of porcine rotavirus A (KS14 strain) inner capsid protein, VP6, and outer capsid protein, VP7. Initially, VP6 was fused with Strep-tag II and FLAG-tag (T-VP6), and T-VP6 was fused further with the signal peptide of Bombyx mori 30k6G protein (30...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Tatsuya, Kakuta, Tatsuki, Yonezuka, Ami, Sekiguchi, Tomofumi, Machida, Yuki, Xu, Jian, Suzuki, Tohru, Park, Enoch Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376036/
https://www.ncbi.nlm.nih.gov/pubmed/35963985
http://dx.doi.org/10.1007/s12033-022-00548-3
_version_ 1784768077371539456
author Kato, Tatsuya
Kakuta, Tatsuki
Yonezuka, Ami
Sekiguchi, Tomofumi
Machida, Yuki
Xu, Jian
Suzuki, Tohru
Park, Enoch Y.
author_facet Kato, Tatsuya
Kakuta, Tatsuki
Yonezuka, Ami
Sekiguchi, Tomofumi
Machida, Yuki
Xu, Jian
Suzuki, Tohru
Park, Enoch Y.
author_sort Kato, Tatsuya
collection PubMed
description In this study, silkworm larvae were used for expression of porcine rotavirus A (KS14 strain) inner capsid protein, VP6, and outer capsid protein, VP7. Initially, VP6 was fused with Strep-tag II and FLAG-tag (T-VP6), and T-VP6 was fused further with the signal peptide of Bombyx mori 30k6G protein (30k-T-VP6). T-VP6 and 30 k-T-VP6 were then expressed in the fat body and hemolymph of silkworm larvae, respectively, with respective amounts of 330 μg and 50 μg per larva of purified protein. Unlike T-VP6, 30k-T-VP6 was N-glycosylated due to attached signal peptide. Also, VP7 was fused with PA-tag (VP7-PA). Additionally, VP7 was fused with Strep-tag II, FLAG-tag, and the signal peptide of Bombyx mori 30k6G protein (30k-T-ΔVP7). Both VP7-PA and 30k-T-ΔVP7 were expressed in the hemolymph of silkworm larvae, with respective amounts of 26 μg and 49 μg per larva of purified protein, respectively. The results from our study demonstrated that T-VP6 formed nanoparticles of greater diameter compared with the ones formed by 30k-T-VP6. Also, higher amount of VP6 expressed in silkworm larvae reveal that VP6 holds the potential for its use in vaccine development against porcine rotavirus with silkworm larvae as a promising host for the production of such multi-subunit vaccines.
format Online
Article
Text
id pubmed-9376036
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-93760362022-08-15 Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate Kato, Tatsuya Kakuta, Tatsuki Yonezuka, Ami Sekiguchi, Tomofumi Machida, Yuki Xu, Jian Suzuki, Tohru Park, Enoch Y. Mol Biotechnol Original Paper In this study, silkworm larvae were used for expression of porcine rotavirus A (KS14 strain) inner capsid protein, VP6, and outer capsid protein, VP7. Initially, VP6 was fused with Strep-tag II and FLAG-tag (T-VP6), and T-VP6 was fused further with the signal peptide of Bombyx mori 30k6G protein (30k-T-VP6). T-VP6 and 30 k-T-VP6 were then expressed in the fat body and hemolymph of silkworm larvae, respectively, with respective amounts of 330 μg and 50 μg per larva of purified protein. Unlike T-VP6, 30k-T-VP6 was N-glycosylated due to attached signal peptide. Also, VP7 was fused with PA-tag (VP7-PA). Additionally, VP7 was fused with Strep-tag II, FLAG-tag, and the signal peptide of Bombyx mori 30k6G protein (30k-T-ΔVP7). Both VP7-PA and 30k-T-ΔVP7 were expressed in the hemolymph of silkworm larvae, with respective amounts of 26 μg and 49 μg per larva of purified protein, respectively. The results from our study demonstrated that T-VP6 formed nanoparticles of greater diameter compared with the ones formed by 30k-T-VP6. Also, higher amount of VP6 expressed in silkworm larvae reveal that VP6 holds the potential for its use in vaccine development against porcine rotavirus with silkworm larvae as a promising host for the production of such multi-subunit vaccines. Springer US 2022-08-13 2023 /pmc/articles/PMC9376036/ /pubmed/35963985 http://dx.doi.org/10.1007/s12033-022-00548-3 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Kato, Tatsuya
Kakuta, Tatsuki
Yonezuka, Ami
Sekiguchi, Tomofumi
Machida, Yuki
Xu, Jian
Suzuki, Tohru
Park, Enoch Y.
Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate
title Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate
title_full Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate
title_fullStr Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate
title_full_unstemmed Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate
title_short Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate
title_sort expression and purification of porcine rotavirus structural proteins in silkworm larvae as a vaccine candidate
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376036/
https://www.ncbi.nlm.nih.gov/pubmed/35963985
http://dx.doi.org/10.1007/s12033-022-00548-3
work_keys_str_mv AT katotatsuya expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate
AT kakutatatsuki expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate
AT yonezukaami expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate
AT sekiguchitomofumi expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate
AT machidayuki expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate
AT xujian expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate
AT suzukitohru expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate
AT parkenochy expressionandpurificationofporcinerotavirusstructuralproteinsinsilkwormlarvaeasavaccinecandidate